Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021.

Journal of Korean medical science - 8 Feb 2021

Yoo Jin Hong

Abstract excerpt

Coronavirus disease 2019 (COVID-19), which started at the end of 2019 and has spread worldwide, has remained unabated in 2021. Since non-pharmaceutical interventions including social distancing are facing limitations in controlling COVID-19, additional absolute means to change the trend are necessary. To this end, coronavirus-specific antiviral drugs and vaccines are urgently needed, but for now, the priority is...

Topics

Join the communities discussing this publication.

Adenoviridae
COVID-19
COVID-19 Vaccines
Genetic Variation
Genetic Vectors
RNA, Messenger

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33559409
DOI: 10.3346/jkms.2021.36.e54
PMCID: PMC7870421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021.PMID 33559409Read ↗

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read ↗

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read ↗

COVID-19 and COVID-19 Vaccine in Japan—A Review from a General Physician's PerspectiveSemantic proximity Read ↗

COVID-19 Vaccines: Where Do We Stand at the End of 2023?Semantic proximity Read ↗

Study of Awareness Regarding Covid-19 Vaccines Among General PopulationSemantic proximity Read ↗

Effectiveness of COVID‑19 vaccines and their challenges (Review)Semantic proximity Read ↗

An Overview of Vaccine Development for COVID-19Semantic proximity Read ↗

COVID-19 vaccines: breaking record times to first-in-human trialsSemantic proximity Read ↗

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read ↗

Randomized COVID-19 Vaccination RolloutSemantic proximity Read ↗

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read ↗

Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, December 2021 - May 2022Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.